Retacrit Alternatives Compared
Retacrit (epoetin alfa) | Aranesp (darbepoetin alfa) | Procrit (epoetin alfa) |
|
---|
Retacrit (epoetin alfa) | Aranesp (darbepoetin alfa) | Procrit (epoetin alfa) |
|
|||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Anemia Due to Chronic Kidney Disease, Anemia, Anemia - Chemotherapy Induced, Anemia Prior to Surgery, Anemia - Drug Induced. Retacrit may also be used for purposes not listed in this... View more |
Prescription only
Prescribed for Anemia Due to Chronic Kidney Disease, Anemia - Chemotherapy Induced. Aranesp may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Anemia Due to Chronic Kidney Disease, Anemia, Anemia - Chemotherapy Induced, Anemia Prior to Surgery, Anemia - Drug Induced. Procrit may also be used for purposes not listed in this... View more |
Related suggestions Anemia Due to Chronic Kidney Disease
Anemia, Chemotherapy Induced
|
|||||||||||||||||||||||
More about Retacrit (epoetin alfa) | More about Aranesp (darbepoetin alfa) | More about Procrit (epoetin alfa) | ||||||||||||||||||||||||
Ratings & Reviews | ||||||||||||||||||||||||||
Retacrit has an average rating of 4.5 out of 10 from a total of 2 ratings on Drugs.com. 50% of reviewers reported a positive effect, while 50% reported a negative effect. |
Aranesp has an average rating of 9.0 out of 10 from a total of 4 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Procrit has an average rating of 4.0 out of 10 from a total of 6 ratings on Drugs.com. 17% of reviewers reported a positive effect, while 50% reported a negative effect. |
||||||||||||||||||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||||||||||
View all Retacrit side effects |
View all Aranesp side effects |
View all Procrit side effects |
||||||||||||||||||||||||
Drug Class | ||||||||||||||||||||||||||
Generic Availability | ||||||||||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Retacrit prices |
View all Aranesp prices |
View all Procrit prices |
||||||||||||||||||||||||
Dosage Forms | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
Brand Names | ||||||||||||||||||||||||||
Other epoetin alfa brands include: Epogen, Procrit |
N/A |
Other epoetin alfa brands include: Epogen, Retacrit | ||||||||||||||||||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||||||||||
19 hours |
49 hours |
19 hours |
||||||||||||||||||||||||
CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
Pregnancy Category | ||||||||||||||||||||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||||||||||
Drug Interactions | ||||||||||||||||||||||||||
A total of 21 drugs are known to interact with Retacrit:
|
A total of 21 drugs are known to interact with Aranesp:
|
A total of 21 drugs are known to interact with Procrit:
|
||||||||||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
Disease Interactions | ||||||||||||||||||||||||||
First Approval Date | ||||||||||||||||||||||||||
N/A |
September 17, 2001 |
N/A |
||||||||||||||||||||||||
WADA Class View classifications | ||||||||||||||||||||||||||
More Information | ||||||||||||||||||||||||||
Patient Resources | ||||||||||||||||||||||||||
Professional Resources | ||||||||||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.